Insider Transactions in Q3 2022 at Uro Gen Pharma Ltd. (URGN)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2022
|
Arie Belldegrun Director |
BUY
Exercise of conversion of derivative security
|
Direct |
160,000
+28.13%
|
$800,000
$5.0 P/Share
|
|
Aug 31
2022
|
Jason Drew Smith General Counsel |
SELL
Open market or private sale
|
Direct |
3,606
-22.85%
|
$25,242
$7.21 P/Share
|
|
Aug 31
2022
|
Jason Drew Smith General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+34.56%
|
-
|
|
Aug 31
2022
|
Arie Belldegrun Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,241
+1.29%
|
$16,205
$5.0 P/Share
|
|
Aug 01
2022
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
259
-1.08%
|
$1,813
$7.81 P/Share
|
|
Jul 31
2022
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.04%
|
-
|